CH 9 Pharmacotherapy of the PEDIATRIC Patient Flashcards Preview

Pharmacology 1 > CH 9 Pharmacotherapy of the PEDIATRIC Patient > Flashcards

Flashcards in CH 9 Pharmacotherapy of the PEDIATRIC Patient Deck (7)
Loading flashcards...
1

Authorizes the FDA to contract for the testing of already approved pediatric drugs, or when the pharmaceutical company declines the option of exclusivity:

Best Pharmaceuticals for Children Act (BPCA)

2

Method of calculating pediatric dosages using an estimate of the child's BSA:

Body surface area (BSA) method

3

Method of calculating pediatric dosages that requires a calculation of the number of milligrams of drug, based on the child's weight in kilograms (mg/kg):

Body weight method

4

Requires that a health care provider directly observe the patient swallowing the pills, whether it is in the hospital, office, or home care setting:

Directly observed therapy (DOT)

5

Act that gave financial incentives to pharmaceutical companies to conduct pediatric research in pharmacology; in exchange for providing pediatric labeling, the legislation gives drug companies the ability to exclusively market the drug for an additional 6 months with no competition:

Food and Drug Administration (FDA) Modernization Act

6

Chart used to plot a child's height and weight to determine body surface area:

Nomogram

7

Act that authorizes the FDA to require research of pediatric uses for new drugs:

Pediatric Research Equity Act of 2003